This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62803855
rdf:type
wikibase:Item
schema:description
scientific article published on 01 November 2014 wetenschappelijk artikel artículu científicu espublizáu en payares de 2014 наукова стаття, опублікована в листопаді 2014 im November 2014 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q62803855-EE6DA821-4E32-4FA6-A4A2-A67EBA964371
wdt:P577
2014-11-01T00:00:00Z
p:P2093
wds:Q62803855-0182B969-BE1F-4963-AD1A-F55FF915CD45
wdt:P2093
Valentina Del Prete
rdfs:label
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
skos:prefLabel
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
schema:name
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
p:P50
wds:Q62803855-AC9B0A0C-1889-438D-9170-B35D7F421D06 wds:Q62803855-CAA8E31E-11EA-4104-83AD-E2541786C4C0 wds:Q62803855-CEED4EE3-3736-4681-8CAE-2D3E188A2BA3 wds:Q62803855-4DFA157A-8220-4137-96E4-A9341732E979 wds:Q62803855-332C02AB-CB64-44B1-8F30-6E7A5141C834 wds:Q62803855-0397C716-70B4-4504-91F9-DC074B1662AB wds:Q62803855-0F823580-73C6-40F8-9D8F-3444F872B0FC
wdt:P50
wd:Q43199975 wd:Q114726457 wd:Q114726458 wd:Q41526393 wd:Q114726459 wd:Q46469728 wd:Q88564221
p:P1476
wds:Q62803855-F208721C-558A-4B84-BB30-CD0F3F5C45FA
wdt:P1476
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
p:P304
wds:Q62803855-394F252B-974D-4383-A09C-C5ABFD097295
wdt:P304
1905-1910
p:P31
wds:Q62803855-170D7975-758B-43BF-A7B7-5CD613D225EB
wdt:P31
wd:Q13442814
p:P921
wds:Q62803855-6CD60D60-D288-49AA-AE4B-E40073B0F440
wdt:P921
wd:Q1148337
p:P698
wds:Q62803855-2C67CFCA-87EB-4339-BA08-0768431FC429
wdtn:P698
n11:24731153
wdt:P698
24731153
p:P1433
wds:Q62803855-FD010983-91CC-4D0C-8F78-488754B71CA6
wdt:P1433
wd:Q15764401
p:P433
wds:Q62803855-07495824-5645-41FE-85D2-EA9D4AE7B970
p:P478
wds:Q62803855-1624987B-2C52-4B61-B00B-F2DA9CD9F401
wdt:P433
11
wdt:P478
29
p:P356
wds:Q62803855-AC6FA2A9-B034-42D2-AD47-8564F342057C
wdtn:P356
n12:JGH.12618
wdt:P356
10.1111/JGH.12618